Characterization of a WaaF (RfaF) homolog expressed by haemophilus ducreyi

Infection and Immunity

Volumn 67, Issue 2, 1999, Pages 899-907

  Bauer, Beth A ^a   Lumbley, Sheryl R ^a   Hansen, Eric J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BACTERIUM LIPOPOLYSACCHARIDE; GENE PRODUCT; OLIGOSACCHARIDE; PROTEIN WAAF; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GENE; BACTERIAL VIRULENCE; GENE EXPRESSION; HAEMOPHILUS DUCREYI; INFLAMMATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RABBIT; SEXUALLY TRANSMITTED DISEASE; SKIN DEFECT; SKIN INFLAMMATION; ULCUS MOLLE;

HAEMOPHILUS DUCREYI; SALMONELLA TYPHIMURIUM;

EID: 0032949301     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.2.899-907.1999     Document Type: Article

References (81)

1. Ahmed, H. J., A. Frisk, J.-E. Månsson, E. K. H. Schweda, and T. Lagergård. 1997. Structurally defined epitopes of Haemophilia ducreyi lipooligosaccharides recognized by monoclonal antibodies. Infect. Immun. 65:3151-3158.
2. Alfa, M. J., P. DeGagne, and P. A. Totten. 1996. Haemophilus ducreyi hemolysin acts as a contact cytotoxin and damages human foreskin fibroblasts in cell culture. Infect. Immun. 64:2349-2352.
3. Allen, A. G., T. Isobe, and D. J. Maskell. 1998. Identification and cloning of waaF (rfaF) from Bordetella pertussis and use to generate mutants of Bordetella spp. with deep rough lipopolysaccharide. J. Bacteriol. 180:35-40.
4. Altschul, S. F., W. Gish, W. Miller, E. W. Myers, and D. J. Lipman. 1990. Basic local alignment search tool. J. Mol. Biol. 215:403-410.
5. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. A. Smith, J. G. Seidman, and K. Struhl. 1990. Current protocols in molecular biology. Greene Publishing Associates and Wiley-Interscience, New York, N.Y.
6. Bauer, B. A., M. K. Stevens, and E. J. Hansen. 1998. Involvement of the Haemophilus ducreyi gmhA gene product in lipooligosaccharide expression and virulence. Infect. Immun. 66:4290-4298.
7. Brentjens, R. J., M. Ketterer, M. A. Apicella, and S. M. Spinola. 1996. Fine tangled pili expressed by Haemophilus ducreyi are a novel class of pili. J. Bacteriol. 178:808-816.
8. Brentjens, R. J., S. M. Spinola, and A. A. Campagnari. 1994. Haemophilus ducreyi adheres to human keratinocytes. Microb. Pathog. 16:243-247.
9. Campagnari, A. A., R. Karalus, M. Apicella, W. Melaugh, A. J. Lesse, and B. W. Gibson. 1994. Use of pyocin to select a Haemophilus ducreyi variant defective in lipooligosaccharide biosynthesis. Infect. Immun. 62:2379-2386.
10. Campagnari, A. A., S. M. Spinola, A. J. Lesse, V. A. Kwaik, R. E. Mandrell, and M. A. Apicella. 1990. Lipooligosaccharide epitopes shared among gramnegative non-enteric mucosal pathogens. Microb. Pathog. 8:353-362.
11. Campagnari, A. A., L. M. Wild, G. E. Griffiths, R. J. Karalus, M. A. Wirth, and S. M. Spinola. 1991. Role of lipooligosaccharides in experimental dermal lesions caused by Haemophilus ducreyi. Infect. Immun. 59:2601-2608.
12. Carson, S. D. B., C. E. Thomas, and C. Elkins. 1996. Cloning and sequencing of a Haemophilus ducreyi fur homolog. Gene 176:125-129.
13. Cope, L. D., S. R. Lumbley, J. L. Latimer, J. Klesney-Tait, M. K. Stevens, L. S. Johnson, M. Purven, R. S. Munson, Jr., T. Lagergård, J. D. Radolf, and E. J. Hansen. 1997. A diffusible cytotoxin of Haemophilus ducreyi. Proc. Natl. Acad. Sci. USA 94:4056-4061.
14. de Kievit, T. R., and J. S. Lam. 1997. Isolation and characterization of two genes, waaC (rfaC) and waaF (rfaF), involved in Pseudomonas aeruginosa serotype O5 inner-core biosynthesis. J. Bacteriol. 179:3451-3457.
15. Dixon, L. G., W. L. Albritton, and P. J. Willson. 1994. An analysis of the complete nucleotide sequence of the Haemophilus ducreyi broad-host-range plasmid pLS88. Plasmid 32:228-232.
16. Elkins, C., C.-J. Chen, and C. E. Thomas. 1995. Characterization of the hgbA locus encoding a hemoglobin receptor from Haemophilus ducreyi. Infect. Immun. 63:2194-2200.
17. Fellay, R., J. Frey, and H. M. Krisch. 1987. Interposon mutagenesis of soil and water bacteria: a family of DNA fragments designed for in vitro insertional mutagenesis of gram negative bacteria. Gene 52:147-152.
18. Ferro-Luzzi Ames, G., E. N. Spudich, and H. Nikaido. 1974. Protein composition of the outer membrane of Salmonella typhimurium: effect of lipopolysaccharide mutations. J. Bacteriol. 117:406-416.
19. Filip, C., G. Fletcher, J. L. Wulff, and C. F. Earhart. 1973. Solubilization of the cytoplasmic membrane of Escherichia coli by the ionic detergent sodium-lauryl sarcosinate. J. Bacteriol. 115:717-722.
20. Fleischmann, R. D., M. D. Adams, O. White, R. A. Clayton, E. F. Kirkness. A. R. Kerlavage, C. J. Bult, J.-F. Tomb, B. A. Dougherty, J. M. Merrick, K. McKenney, G. Sutton, W. FitzHugh, C. Fields, J. D. Gocayne, J. Scott, R. Shirley, L.-I. Liu, A. Glodek, J. M. Kelley, J. F. Weidman, C. A. Phillips, T. Spriggs, E. Hedblom, M. D. Cotton, R. C. Utterback, M. C. Hanna, D. T. Nguyen, D. M. Saudek, R. C. Brandon, L. D. Fine, J. L. Frichman, J. L. Fuhrmann, N. S. M. Geoghagen, C. L. Gnehm, L. A. McDonald, K. V. Small, C. M. Fraser, H. O. Smith, and J. C. Venter. 1995. Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science 269:496-512.
21. Gibson, B. W., A. A. Campagnari, W. Melaugh, N. J. Phillips, M. A. Apicella, S. Grass, J. Wang, K. L. Palmer, and R. S. Munson, Jr. 1997. Characterization of a transposon Tn916-generated mutant of Haemophilus ducreyi 35000 defective in lipooligosaccharide biosynthesis. J. Bacteriol. 179:5062-5071.
22. Gibson, B. W., W. Melaugh, N. J. Phillips, M. A. Apicella, A. A. Campagnari, and J. M. Griffiss. 1993. Investigation of the structural heterogeneity of lipooligosaccharides from pathogenic Haemophilus and Neisseria species and of R-type lipopolysaccharides from Salmonella typhimurium by electrospray mass spectrometry. J. Bacteriol. 175:2702-2712.
23. Hammond, G. W., C. J. Lian, J. C. Wilt, and A. R. Ronald. 1978. Antimicrobial susceptibility of Haemophilus ducreyi. Antimicrob. Agents Chemother. 13:608-612.
24. Hansen, E. J., J. L. Latimer, S. E. Thomas, M. Helminen, W. L. Albritton, and J. D. Radolf. 1992. Use of electroporation to construct isogenic mutants of Haemophilus ducreyi. J. Bacteriol. 174:5442-5449.
25. Hansen, E. J., S. R. Lumbley, H. Saxen, K. Kern, L. D. Cope, and J. D. Radolf. 1995. Detection of Haemophihts ducreyi lipooligosaccharide by means of an immunolimulus assay. J. Immunol. Methods 185:225-235.
26. Helander, I. M., B. Lindner, H. Brade, K. Altmann, A. A. Lindberg, E. T. Rietschel, and U. Zahringer. 1988. Chemical structure of the lipopolysaccharide of Haemophilus ducreyi strain I-69 Rd-/b+: description of a novel deep-rough chemotype. Eur. J. Biochem. 177:483-492.
27. Hennessy, K. J., J. J. Iandolo, and B. W. Fenwick. 1993. Serotype identification of Actinobacillus pleuropneumoniae by arbitrarily primed polymerase chain reaction. J. Clin. Microbiol. 31:1155-1159.
28. Hobbs, M. M., T. R. Paul, P. B. Wyrick, and T. H. Kawula. 1998. Haemophilus ducreyi infection causes basal keratinocyte cytotoxicity and elicits a unique cytokine induction pattern in an in vitro human skin model. Infect. Immun. 66:2914-2921.
29. Hobbs, M. M., L. R. San Mateo, P. E. Orndorff, G. Almond, and T. H. Kawula. 1995. Swine model of Haemophilus ducreyi infection. Infect Immun. 63:3094-3100.
30. Hood, D. W., M. E. Deadman, T. Allen, H. Masoud, A. Martin, J. R. Brisson, R. Fleischmann, J. C. Venter, J. C. Richards, and E. R. Moxon. 1996. Use of the complete genome sequence information of Haemophilia influenzae strain Rd to investigate lipopolysaccharide biosynthesis. Mol. Microbiol. 22:951-965.
31. Inzana, T. J., and L. B. Corbeil. 1987. Development of a defined medium for Haemophilus somnus isolated from cattle. Am. J. Vet. Res. 48:366-369.
32. Jackson, A. D., D. Maskell, E. R. Moxon, and R. Wilson. 1996. The effect of mutations in genes required for lipopolysaccharide synthesis on Haemophilus influenzae type b colonization of human nasopharyngeal tissue. Microb. Pathog. 21:463-470.
33. Jennings, M. P., M. Bisercic, K. L. R. Dunn, M. Virji, A. Martin, K. E. Wilks, J. C. Richards, and E. R. Moxon. 1995. Cloning and molecular analysis of the lsil (rfaF) gene of Neisseria meningitidis which encodes a heptosyl-2-transferase involved in LPS mediated toxicity for human endothelial cells. Microb. Pathog. 19:391-407.
34. Kimura, A., and E. J. Hansen. 1986. Antigenic and phenotypic variations of Haemophilus influenzas type b lipopolysaccharide and their relationship to virulence. Infect. Immun. 51:69-79.
35. Klena, J. D., E. Pradel, and C. A. Schnaitman. 1992. Comparison of lipopolysaccharide biosynthesis genes rfaK, rfaL, rfaY, and rfaZ of Escherichia coli K-12 and Salmonella typhimurium. J. Bacteriol. 174:4746-4752.
36. Klesney-Tait, J., T. J. Hiltke, I. Maciver, S. M. Spinola, J. D. Radolf, and E. J. Hansen. 1997. The major outer membrane protein of Haemophilus ducreyi consists of two OmpA homologs. J. Bacteriol. 179:1764-1773.
37. Koplow, J., and H. Goldfine. 1974. Alterations in the outer membrane of the cell envelope of heptose-deficient mutants of Escherichia coli. J. Bacteriol. 117:527-543.
38. Lammel, C. J., N. P. Dekker, J. Palefsky, and G. F. Brooks. 1993. In vitro model of Haemophilus ducreyi adherence to and entry into eukaryotic cells of genital origin. J. Infect. Dis. 167:642-650.
39. Langford, P. R., and J. S. Kroll. 1997. Distribution, cloning, characterization and mutagenesis of sodC, the gene encoding copper/zinc superoxide dismutase, a potential determinant of virulence in Haemophilus ducreyi. FEMS Immunol. Med. Microbiol. 17:235-242.
40. Lesse, A. J., A. A. Campagnari, W. E. Bittner, and M. A. Apicella. 1990. Increased resolution of lipopolysaccharides and lipooligosaccharides utilizing tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis. J. Immunol. Methods 126:109-117.
41. Mandrell, R. E., R. McLaughlin, Y. A. Kwaik, A. Lesse, R. Yamasaki, B. Gibson, S. M. Spinola, and M. A. Apicella. 1992. Lipooligosaccharides (LOS) of some Haemophilus species mimic human glycosphingolipids, and some LOS are sialylated. Infect. Immun. 60:1322-1328.
42. Melaugh, W., A. A. Campagnari, and B. W. Gibson. 1996. The lipooligosaccharides of Haemophilus ducreyi are highly sialylated. J. Bacteriol. 178:564-570.
43. Melaugh, W., N. J. Phillips, A. A. Campagnari, M. V. Tullius, and B. W. Gibson. 1994. Structure of the major oligosaccharide from the lipooligosaccharide of Haemophilus ducreyi strain 35000 and evidence of additional glycoforms. Biochemistry 33:13070-13078.
44. Nichols, W. A., B. W. Gibson, W. Melaugh, N.-G. Lee, M. Sunshine, and M. A. Apicella. 1997. Identification of the ADP-L-glycero-D-manno-heptose-6-epimerase (rfaD) and heptosyltransferase II (rfaF) biosynthesis genes from nontypeable Haemophilus influenzae 2019. Infect. Immun. 65:1377-1386.
45. Nichols, W. A., C. R. H. Raetz, T. Clementz, A. L. Smith, J. A. Hanson, M. R. Ketterer, M. Sunshine, and M. A. Apicella. 1997. htrB of Haemophilus influence: determination of biochemical activity and effects on virulence and lipooligosaccharide toxicity. J. Endotoxin Res. 8:585-588.
46. Nikaido, H., and M. Vaara. 1985. Molecular basis of bacterial outer membrane permeability. Microbiol. Rev. 49:1-32.
47. Palmer, K. L., W. E. Goldman, and R. S. Munson, Jr. 1996. An isogenic haemolysin-deficient mutant of Haemophilus ducreyi lacks the ability to produce cytopathic effects on human foreskin fibroblasts. Mol. Microbiol. 21: 13-19.
48. Palmer, K. L., S. Grass, and R. S. Munson, Jr. 1994. Identification of a hemolytic activity elaborated by Haemophilus ducreyi. Infect. Immun. 62: 3041-3043.
49. Palmer, K. L., and R. S. Munson, Jr. 1995. Cloning and characterization of the genes encoding the haemolysin of Haemophilus ducreyi. Mol. Microbiol. 18:821-830.
50. Palmer, K. L., A. C. Thornton, K. R. Fortney, R. S. Munson, Jr., and S. M. Spinola. 1998. Evaluation of an isogenic hemolysin-deficient mutant in the human model of Haemophilus ducreyi infection. J. Infect. Dis. 178:191-199.
51. Parsons, L. M., R. J. Limberger, and M. Shayegani. 1997. Alterations in levels of DnaK and GroEL result in diminished survival and adherence of stressed Haemophilus ducreyi. Infect. Immun. 65:2413-2419.
52. Patrick, C. C., A. Kimura, M. A. Jackson, L. Hermanstorfer, A. Hood, G. H. McCracken, Jr., and E. J. Hansen. 1987. Antigenic characterization of the oligosaccharide portion of the lipooligosaccharide of nontypable Haemophilus influence. Infect. Immun. 55:2902-2911.
53. Petricoin, E. F., III, R. J. Danaher, and D. C. Stein. 1991. Analysis of the Isi region involved in lipooligosaccharide biosynthesis in Neisseria gonorrhoeae. J. Bacteriol. 173:7896-7902.
54. Phillips, N. J., R. McLaughlin, T. J. Miller, M. A. Apicella, and B. W. Gibson. 1996. Characterization of two transposon mutants from Haemophilus influenzae type b with altered lipooligosaccharide biosynthesis. Biochemistry 35:5937-5947.
55. Purcell, B. K., J. A. Richardson, J. D. Radolf, and E. J. Hansen. 1991. A temperature-dependent rabbit model for production of dermal lesions by Haemophilus ducreyi. J. Infect. Dis. 164:359-367.
56. Purvén, M., A. Frisk, I. Lönnroth, and T. Lagergȧrd. 1997. Purification and identification of Haemophilus ducreyi cytotoxin by use of a neutralizing monoclonal antibody. Infect. Immun. 65:3496-3499.
57. Reeves, P. R., M. Hobbs, M. A. Valvano, M. Skurnik, C. Whitfield, D. Coplin, N. Kido, J. Klena, D. Maskell, C. R. Raetz, and P. D. Rick. 1996. Bacterial polysaccharide synthesis and gene nomenclature. Trends Microbiol. 4:495-503.
58. Roantree, R. J., T. T. Kuo, and D. G. MacPhee. 1977. The effect of defined lipopolysaccharide core defects upon antibiotic resistances of Salmonella typhimurium. J. Gen. Microbiol. 103:223-234.
59. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
60. San Mateo, L. R., M. M. Hobbs, and T. H. Kawula. 1998. Periplasmic copper-zinc superoxide dismutase protects Haemophilus ducreyi from exogenous superoxide. Mol. Microbiol. 27:391-404.
61. San Mateo, L. R., K. L. Toffer, and T. H. Kawula. 1998. The sodA gene of Haemophilus ducreyi expresses a hydrogen peroxide-inhibitable superoxide dismutase. Gene 207:251-257.
62. Schnaitman, C. A., and J. D. Klena. 1993. Genetics of lipopolysaccharide biosynthesis in enteric bacteria. Microbiol. Rev. 57:655-682.
63. 2 chemotype LPS and do not enter epithelial host cells. Mol. Microbiol. 15:267-275.
64. Schweda, E. K. H., J. A. Jonasson, and P.-E. Jansson. 1995. Structural studies of lipooligosaccharides from Haemophilus ducreyi ITM 5535, ITM 3147, and a fresh clinical isolate, ACY1: evidence for intrastrain heterogeneity with the production of mutually exclusive sialylated or elongated glycoforms. J. Bacteriol. 177:5316-5321.
65. Sirisena, D. M., P. K. MacLachlan, S.-L. Liu, A. Hessel, and K. E. Sanderson. 1994. Molecular analysis of the rfaD gene, for heptose synthesis, and the rfaF gene, for heptose transfer, in lipopolysaccharide synthesis in Salmonella typhimurium. J. Bacteriol. 176:2379-2385.
66. Spinola, S. M., A. Orazi, J. N. Arno, K. R. Fortney, P. Kotylo, C.-Y. Chen, A. A. Campagnari, and A. F. Hood. 1996. Haemophilus ducreyi elicits a cutaneous infiltrate of CD4 cells during experimental human infection, J. Infect. Dis. 173:394-402.
67. Spinola, S. M., L. M. Wild, M. A. Apicella, A. A. Gaspari, and A. A. Campagnari. 1994, Experimental human infection with Haemophilus ducreyi. J. Infect. Dis. 169:1146-1150.
68. Stevens, M. K., J. Klesney-Tait, S. Lumbley, K. A. Walters, A. M. Joffe, J. D. Radolf, and E. J. Hansen. 1997. Identification of tandem genes involved in lipooligosaccharide expression by Haemophilus ducreyi. Infect. Immun. 65: 651-660.
69. Stevens, M. K., S. Porcella, J. Klesney-Tait, S. Lumbley, S. E. Thomas, M. V. Norgard, J. D. Radolf, and E. J. Hansen. 1996. A hemoglobin-binding outer membrane protein is involved in virulence expression by Haemophilus ducreyi in an animal model. Infect. Immun. 64:1724-1735.
70. Stuy, J. H., and R. B. Walter. 1992. Cloning, characterization, and DNA base sequence of the high-level streptomycin resistance gene strA1 of Haemophilus influence Rd. J. Bacteriol. 174:5604-5608.
71. Templeton, N. S. 1992. The polymerase chain reaction: history, methods, and applications. Diagn. Mol. Pathol. 1:58-72.
72. Totten, P. A., J. C. Lara, D. V. Norn, and W. E. Stamm. 1994. Haemophilus ducreyi attaches to and invades human epithelial cells in vitro. Infect. Immun. 62:5632-5640.
73. Totten, P. A., W. R. Morton, G. H. Knitter, A. M. Clark, N. B. Kiviat, and W. E. Stamm. 1994. A primate model for chancroid. J. Infect. Dis. 169:1284-1290.
74. Totten, P. A., D. V. Norn, and W. E. Stamm. 1995. Characterization of the hemolytic activity of Haemophilus ducreyi. Infect. Immun. 63:4409-4416.
75. Trees, D. L., R. J. Arko, and S. A. Morse. 1991. Mouse subcutaneous chamber model form vivo growth of Haemophilus ducreyi. Microb. Pathog. 11: 387-390.
76. Trees, D. L., and S. A. Morse. 1995. Chancroid and Haemophilus ducreyi: an update. Clin. Microbiol. Rev. 8:357-375.
77. Tsai, C.-M., and C. E. Frasch. 1982. A sensitive silver stain for detecting lipopolysaccharide in polyacrylamide gels. Anal. Biochem. 119:115-119.
78. Tuffrey, M., F. Alexander, R. C. Ballard, and D. Taylor-Robinson. 1990. Characterization of skin lesions in mice following intradermal inoculation of Haemophilus ducreyi. J. Exp. Pathol. 71:233-244.
79. Tullius, M. V., R. S. Munson, Jr., J. Wang, and B. W. Gibson. 1996. Purification, cloning, and expression of a cytidine 5′-monophosphate N-acetyl-neuraminic acid synthetase from Haemophilia ducreyi. J. Biol. Chem. 271: 15373-15380.
80. Weiser, J. N., S. T. H. Chong, D. Greenberg, and W. Fong. 1995 Identification and characterization of a cell envelope protein of Haemophilus influenzae contributing to phase variation in colony opacity and nasopharyngeal colonization. Mol. Microbiol. 17:555-564.
81. Weiser, J. N., M. Shchepetov, and S. T. H. Chong. 1997. Decoration of lipopolysaccharide with phosphorylcholine: a phase-variable characteristic of Haemophilus influenzae. Infect. Immun. 65:943-950.